For instance, premiR-377 is used to target EGFR (Epidermal Growth Factor Receptor), which is significantly increased in NSCLC (Non-Small-Cell Lung Cancer), while mimics of miR-34a are useful to target p53 in several solid tumors [103]. Here, TP53 is linked to non-small cell lung carcinoma.